Nureca · NSE: NURECA · BSE: 543264

Q2 FY23 results · Jul–Sep 2022

Nureca reported revenue from operations of ₹36.78 crore (down 21.6% from Q2 FY22) and net loss of ₹2.89 crore for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations36.7846.94−21.6%25.53+44.1%
Other income1.892.11−10.4%1.17+61.4%
Total income38.6749.05−21.2%26.70+44.8%
Profit before tax(3.74)7.71Turned loss(5.30)Loss narrowed
Net profit for the period(2.89)5.43Turned loss(4.13)Loss narrowed
EPS, basic (₹)(2.89)5.43Turned loss(4.13)Loss narrowed
Net margin (%)-7.911.6-16.2
Standalone · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations36.7946.91−21.6%26.06+41.2%
Other income1.912.12−9.8%1.18+62.8%
Total income38.7049.03−21.1%27.23+42.1%
Profit before tax(3.63)7.76Turned loss(5.04)Loss narrowed
Net profit for the period(2.78)5.49Turned loss(3.87)Loss narrowed
EPS, basic (₹)(2.78)5.49Turned loss(3.87)Loss narrowed
Net margin (%)-7.611.7-14.8
Consolidated
Filed with BSE
23 Nov 2022, 17:28 IST
Board meeting
11 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
23 Nov 2022, 17:28 IST
Board meeting
11 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE